$15.88
+0.32 (+2.06%)
Open$15.99
Previous Close$15.56
Day High$16.40
Day Low$15.82
52W High$17.47
52W Low$2.98
Volume—
Avg Volume3.62M
Market Cap3.46B
P/E Ratio—
EPS$-1.57
SectorBiotechnology
Analyst Ratings
Strong Buy
19 analysts
Price Target
+310.8% upside
Current
$15.88
$15.88
Target
$65.23
$65.23
$47.67
$65.23 avg
$99.61
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 19.88M | 8.30M | 220.69M |
| Net Income | -357,929,124 | -252,156,044 | 45.13M |
| Profit Margin | -1,800.6% | -3,206.0% | 20.5% |
| EBITDA | -387,317,831 | -289,236,526 | 96.01M |
| Free Cash Flow | — | — | 41.24M |
| Rev Growth | +123.3% | +48.9% | +11.7% |
| Debt/Equity | — | — | 0.55 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $234.93 | +0.07% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $352.99 | +1.72% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $125.88 | +0.66% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $478.81 | +2.22% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $626.31 | +1.34% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $300.33 | +4.22% | 64.3 | 37.13B |